Brinzolamide/timolol shows modest advantage in morning IOP reduction over dorzolamide/timolol

Brinzolamide/timolol (BT) lowers morning intraocular pressure (IOP) in patients with glaucoma slightly more than dorzolamide/timolol (DT), but the difference is modest, according to a study. The systematic review and meta-analysis of 12 studies included 11 randomized controlled trials and 1,885 patients. Brinzolamide/timolol achieved a statistically greater reduction in morning IOP...